LUPPI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 5.437
EU - Europa 4.967
AS - Asia 535
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 5
Totale 10.978
Nazione #
US - Stati Uniti d'America 5.411
IT - Italia 2.665
GB - Regno Unito 1.050
SE - Svezia 372
DE - Germania 231
CN - Cina 228
FR - Francia 185
UA - Ucraina 171
HK - Hong Kong 98
TR - Turchia 98
FI - Finlandia 95
BG - Bulgaria 59
RU - Federazione Russa 40
IN - India 29
BE - Belgio 27
IE - Irlanda 25
CA - Canada 19
KR - Corea 16
NL - Olanda 15
JP - Giappone 13
VN - Vietnam 12
IR - Iran 11
BR - Brasile 7
AR - Argentina 6
EU - Europa 6
MY - Malesia 6
AU - Australia 5
CL - Cile 5
ES - Italia 4
LB - Libano 4
MX - Messico 4
PL - Polonia 4
TW - Taiwan 4
AT - Austria 3
BZ - Belize 3
CH - Svizzera 3
IQ - Iraq 3
NO - Norvegia 3
PK - Pakistan 3
CZ - Repubblica Ceca 2
HR - Croazia 2
IL - Israele 2
LU - Lussemburgo 2
LV - Lettonia 2
PH - Filippine 2
RO - Romania 2
SA - Arabia Saudita 2
SG - Singapore 2
VE - Venezuela 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TN - Tunisia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 10.978
Città #
Southend 887
Fairfield 792
Chandler 478
Woodbridge 476
Ashburn 444
Houston 394
Ann Arbor 308
Seattle 268
Wilmington 260
Jacksonville 250
Cambridge 243
Dearborn 233
Nyköping 222
Rome 180
Milan 179
Modena 141
San Diego 97
Beijing 96
Hong Kong 96
New York 76
Helsinki 58
Sofia 57
Princeton 56
Izmir 54
Eugene 52
Florence 45
Palermo 42
Redwood City 40
Catania 38
Bologna 36
London 35
Naples 34
Bremen 33
Bari 26
Genoa 26
Turin 26
Brussels 25
Boardman 23
Padova 22
Shanghai 22
Cagliari 19
Mountain View 19
Falls Church 18
Verona 17
Phoenix 16
Salerno 16
Brescia 14
Des Moines 14
Fremont 14
Reggio Emilia 14
Treviso 13
Los Angeles 12
Norwalk 11
Torino 11
Dong Ket 10
Parma 10
Saint Petersburg 10
San Jose 10
Bergamo 9
Hefei 9
Leawood 9
Nonantola 9
Pisa 9
Trieste 9
Frankfurt am Main 8
Guangzhou 8
Kunming 8
Messina 8
Perugia 8
Pescara 8
Atlanta 7
Cisterna di Latina 7
Grafing 7
Livorno 7
Nanjing 7
Reggio Calabria 7
Seongnam-si 7
Trento 7
Andover 6
Calgary 6
Chennai 6
Indiana 6
Monza 6
San Mateo 6
Savona 6
Siena 6
Tivoli 6
Toronto 6
Venice 6
Agliana 5
Ancona 5
Ardabil 5
Avellino 5
Bresso 5
Buenos Aires 5
Caserta 5
Catanzaro 5
Dublin 5
Forlì 5
Jinan 5
Totale 7.397
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 2.567
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 341
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 253
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 240
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 233
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 224
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 218
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 217
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 213
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 212
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 212
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 202
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 200
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 199
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 189
Prognostic role of clusterin in resected adenocarcinomas of the lung. 187
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 184
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 181
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 178
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 177
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 173
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 171
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 168
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 165
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 164
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 163
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 161
Clusterin (CLU) and lung cancer. 159
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 159
Management of Idiopathic Pulmonary Fibrosis 156
Complex chronic co-morbidities of COPD 152
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 148
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 147
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 144
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 140
Treatment of chronic obstructive pulmonary disease and its comorbidities 137
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 135
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 132
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 127
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 127
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 117
Challenges in idiopathic interstitial lung disease 114
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 112
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 110
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 110
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 108
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 106
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 100
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 93
Therapeutic approaches to idiopathic pulmonary fibrosis 92
Malattie infiltrative diffuse del polmone 82
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 80
Medicina personalizzata e fibrosi polmonare idiopatica 69
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 64
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 60
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 41
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 21
Totale 11.134
Categoria #
all - tutte 33.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019630 0 0 0 0 0 0 0 0 0 94 228 308
2019/20202.230 221 90 92 126 221 329 327 256 232 130 133 73
2020/20211.757 170 63 129 170 170 148 129 200 91 218 147 122
2021/20221.458 86 116 113 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20241.678 115 139 156 199 270 224 201 225 60 89 0 0
Totale 11.134